Coiro, an advanced practice nurse practitioner at the John Theurer Cancer Center at Hackensack University Medical Center Stem ...

The most powerful thing we offer is not a medication or a skill: it’s presence. Presence steadies a hand during uncertainty ...

Kristin Daly, MSN, ANP-BC, AOCNP, shares advice for preparing patients for possible adverse effects outside of clinic hours.

Standard treatments recommended by NCCN Guidelines for this setting include fruquintinib (Fruzaqla), regorafenib (Stivarga), ...

The multi-day nature of standard chemotherapy regimens used in extensive-stage small cell lung cancer (ES-SCLC) creates ...

Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...

Luspatercept-aamt (Reblozyl) is among National Comprehensive Cancer Network Guideline recommendations for low-risk MDS.

Panelists discuss how successful talquetamab treatment requires coordinated care between inpatient and outpatient teams, ...

Panelists discuss how comprehensive patient education materials and manufacturer resources help patients prepare for and ...

JADPRO Live 2025 provides a platform for leaders in oncology advanced practice to share research and best practices with ...

Nurse-led telehealth follow-ups may increase emotional well-being for survivors of ovarian cancer, according to data from a ...

Biomarker testing for patients with ovarian cancer should be completed both in the upfront setting and through disease ...